Healthcare PharmaceuticalsLucentis
Owned by Novartis
Anti-VEGF biologic (ranibizumab) for treating retinal diseases including wet AMD and diabetic retinopathy. Developed by Genentech (Roche) and co-commercialized by Novartis outside the United States.
eye-diseasemacular-degenerationdiabetic-retinopathy